Italfarmaco Acticand 30 (8vag.tabs) - For fungal infections of the vulva (Vaginal infections)

The Acticand 30 is a new probiotic product for the treatment of vulvovaginal candidiasis (vaginal thrush), which creates a barrier against potential pathogens in the vagina, especially the Candida.

The Acticand 30 is the product that will provide a solution for women with candidiasis symptoms for the first time , to avoid the possibility of a recurrence , but also to women who suffer from a recurrent candidiasis of the vagina to give a final solution to their problem .

The Acticand 30 is a device in tablets for vaginal administration which comprises prebiotic fibers and Arabinogalactan fruit sakcharites , Lactobacillus L. Fermentum LF10 and L.

Acidophilus LA02, citric acid and sodium bicarbonate.

The Acticand 30 thanks to the presence of citric acid and sodium bicarbonate , but also the particular slow disintegration of the pessary is capable of creating an anaerobic environment in the lumen of the vagina agent CO2, characteristic which counteracts the consolidation , the persistence and proliferation of Candida.

The presence of two Lactobacillus , L. Fermentum LF10 and L.Acidophilus LA02, enhances the action of anaerobic environment .

Lactobacilli release molecules with specific activity , organic acids and low molecular weight peptides including vaktiriolysinon capable to strengthen the fight against vaginal pathogens , especially strains of Candida.

The saccharides from fruits and arabinogalactan are contained in Acticand 30 and are plant fibers that make up the "food" for lactobacilli and help to proliferate and thus have a positive contribution to combating Candida albicans of vaginitis or other types of Candida. 

Suggested usage : 

Apply a vaginal tablet once a day for 7 consecutive nights, followed by 1 tablet every 3 nights for a further 3-week application (acute phase) and, finally, 1 tablet per week to maintain a long-term vaginal colonization against possible recurrences.

The product Acticand 30 circulates into tablets for vaginal use dissolve rapidly , within 30 minutes after administration .